These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 6285736)

  • 21. Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine.
    Larsson A; Alenius S; Johansson NG; Oberg B
    Antiviral Res; 1983 Aug; 3(2):77-86. PubMed ID: 6312878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    De Clercq E; Descamps J; Balzarini J; Fukui T; Allaudeen HS
    Biochem J; 1983 May; 211(2):439-45. PubMed ID: 6307280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
    Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes viruses.
    Bennett LL; Shealy YF; Allan PW; Rose LM; Shannon WM; Arnett G
    Biochem Pharmacol; 1990 Oct; 40(7):1515-22. PubMed ID: 2171531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
    Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
    Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of the herpes simplex virus-coded thymidine kinase-complex by 9-beta-D-arabinofuranosyladenine 5'-monophosphate (ara-AMP) and 9-(2-hydroxyethoxymethyl)guanine-monophosphate (acyclo-GMP).
    Labenz J; Müller WE; Falke D
    Arch Virol; 1984; 81(3-4):205-12. PubMed ID: 6206825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
    Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
    N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine.
    Terry BJ; Cianci CW; Hagen ME
    Mol Pharmacol; 1991 Oct; 40(4):591-6. PubMed ID: 1656194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 30. Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.
    Knopf KW; Kaufman ER; Crumpacker C
    J Virol; 1981 Sep; 39(3):746-57. PubMed ID: 6270349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility of varicella-zoster virus to acyclovir.
    Biron KK; Elion GB
    Antimicrob Agents Chemother; 1980 Sep; 18(3):443-7. PubMed ID: 6252836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
    Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells.
    Hodge RA; Perkins RM
    Antimicrob Agents Chemother; 1989 Feb; 33(2):223-9. PubMed ID: 2541655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acyclovir on the deoxyribonucleoside triphosphate pool levels in Vero cells infected with herpes simplex virus type 1.
    Furman PA; Lambe CU; Nelson DJ
    Am J Med; 1982 Jul; 73(1A):14-7. PubMed ID: 6285704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymidine kinase not required for antiviral activity of acyclovir against mouse cytomegalovirus.
    Burns WH; Wingard JR; Bender WJ; Saral R
    J Virol; 1981 Sep; 39(3):889-93. PubMed ID: 6270357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.
    Biron KK; Fyfe JA; Noblin JE; Elion GB
    Am J Med; 1982 Jul; 73(1A):383-6. PubMed ID: 6285728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation and antiviral effect of acyclovir in cells infected with a varicella-like simian virus.
    Fyfe JA; Biron KK; McKee SA; Kelly CM; Elion GB; Soike KF
    Am J Med; 1982 Jul; 73(1A):58-61. PubMed ID: 6285734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chemotherapeutic exploitation of virus-specified enzymes.
    Elion GB
    Adv Enzyme Regul; 1980; 18():53-66. PubMed ID: 6255770
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
    Field HJ; Larder BA; Darby G
    Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
    Tenser RB; Gaydos A; Hay KA
    J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.